Noor hatef aldabagh (10 risultati)

Condizione: New. pp. 216.

Taschenbuch. Condizione: Neu. Design, and Synthesis of Novel Anti - tuberculosis Agents | Design,Synthesis and Anti-tuberculosis Evaluation of Ciprofloxacin-Sulfonamide Conjugates using Hybridization Approach | Noor Hatef Aldabagh (u. a.) | Taschenbuch | 216 S. | Englisch | 2017 | Scholars' Press | EAN 9786202301961 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.…

Paperback. Condizione: Brand New. 216 pages. 8.66x5.91x0.49 inches. In Stock.

paperback. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Tuberculosis (TB) is an airborne global disease, which is typically caused by the Gram-positive bacterium Mycobacterium tuberculosis (Mtb). It remains to be one of the major infectious diseases globally.Despite 40 years of anti-TB chemotherapy, tuberculosis remains one of the leading infectious diseases worldwide. Among the main obstacles to the global control of the disease are the HIV epidemic that has dramatically increased risk for developing active TB, the increasing emergence of multi-drug resistant TB and the recalcitrance of persistent infections to treatment with conventional anti-TB drugs.The situation is exacerbated by the increasing emergence of extensively drug-resistant TB. A potential approach to overcome the resistance problem is to design novel and innovative agents. The development of new antibiotics can be achieved from derivatives of known antimicrobial agents or by identification of novel agents active against previously unexploited targets.Thus, keeping in view the need of novel antibacterial agents with improved antimicrobial profile, and as a part of our ongoing programme on design and discovery of novel pharmacotherapeutic and antimicrobial agents. 216 pp. Englisch.…

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Aldabagh Noor HatefNoor Aldabagh and Mohammed Hassan are pharmacists Ph.D in pharmaceutical chemistry. They are interesting with researches associated with design and chemical synthesis of novel compounds that targeting specific rec.…

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Tuberculosis (TB) is an airborne global disease, which is typically caused by the Gram-positive bacterium Mycobacterium tuberculosis (Mtb). It remains to be one of the major infectious diseases globally.Despite 40 years of anti-TB chemotherapy, tuberculosis remains one of the leading infectious diseases worldwide. Among the main obstacles to the global control of the disease are the HIV epidemic that has dramatically increased risk for developing active TB, the increasing emergence of multi-drug resistant TB and the recalcitrance of persistent infections to treatment with conventional anti-TB drugs.The situation is exacerbated by the increasing emergence of extensively drug-resistant TB. A potential approach to overcome the resistance problem is to design novel and innovative agents. The development of new antibiotics can be achieved from derivatives of known antimicrobial agents or by identification of novel agents active against previously unexploited targets.Thus, keeping in view the need of novel antibacterial agents with improved antimicrobial profile, and as a part of our ongoing programme on design and discovery of novel pharmacotherapeutic and antimicrobial agents.…

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Tuberculosis (TB) is an airborne global disease, which is typically caused by the Gram-positive bacterium Mycobacterium tuberculosis (Mtb). It remains to be one of the major infectious diseases globally.Despite 40 years of anti-TB chemotherapy, tuberculosis remains one of the leading infectious diseases worldwide. Among the main obstacles to the global control of the disease are the HIV epidemic that has dramatically increased risk for developing active TB, the increasing emergence of multi-drug resistant TB and the recalcitrance of persistent infections to treatment with conventional anti-TB drugs.The situation is exacerbated by the increasing emergence of extensively drug-resistant TB. A potential approach to overcome the resistance problem is to design novel and innovative agents. The development of new antibiotics can be achieved from derivatives of known antimicrobial agents or by identification of novel agents active against previously unexploited targets.Thus, keeping in view the need of novel antibacterial agents with improved antimicrobial profile, and as a part of our ongoing programme on design and discovery of novel pharmacotherapeutic and antimicrobial agents.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 216 pp. Englisch.…

Condizione: New. Print on Demand pp. 216.

Condizione: New. PRINT ON DEMAND pp. 216.